24 May 2013
Keywords: chiron, submits, nda, pulminiq, biotechnology, major, corp
Article | 25 October 2004
US biotechnology major Chiron Corp has filed a New Drug Application to the US Food and Drug Administration for marketing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 October 2004
© 2013 thepharmaletter.com